The FDA's Sandra Kweder reported that the agency and an Indian company have worked out a deal for the importation of a temporary replacement to Doxil, an essential cancer treatment that has been running short in the U.S. since June. The FDA also averted a shortage of the children's leukemia drug methotrexate by urging generic-drug makers to boost production, Kweder said.
FDA moves to ease cancer drug shortage
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||